ArticleScientific reports2025
Study on the crack resistance of USP warm-mix rubber asphalt and its mixtures.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study addresses the high mixing temperatures, high viscosity, and low-temperature cracking of rubber-modified asphalt (AR) and evaluates the modification performance of a domestically developed USP warm-mix technology. USPA-R and USPA-C2 are used to prepare warm-mix rubberized asphalt, and corresponding mixtures are designed with AC-13 and SMA-13 gradations. Penetration, softening point, ductility, viscosity, BBR, DDT, fluorescence analysis, and three-point bending tests are conducted in accordance with relevant standards, and ABAQUS simulations are integrated to elucidate mechanisms and quantify performance responses. The results show that both warm-mix additives improve the conventional properties and low-temperature deformation resistance of asphalt concrete (AC), with USPA-C2 exhibiting superior performance. In three-point bending, AC-13 generally outperforms SMA-13; relative to AC-R, USPA-C2 increases the maximum flexural strain by approximately 252 µε, whereas USPA-R yields an increase of about 142 µε. When fibers are incorporated, crack resistance is further enhanced, with basalt fiber providing the greatest benefit (≈ 16.8% improvement at - 10 °C). Mechanistically, the warm-mix agents are understood to promote binder mobility and energy dissipation by modulating asphalt-fraction distribution and intermolecular interactions. Overall, low-temperature crack resistance is substantially increased while required construction temperatures are reduced, thereby extending service life, decreasing curing demands, and delivering energy-saving and emission-reduction benefits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.